Synthecon

Name

Synthecon

Legal name

Synthecon, Incorporated

Website

https://synthecon.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

3D Cell Culture Bioreactor Equipment

NAICS

Plastics Product Manufacturing (3261)

SIC

Plastics Products, Nec (3089)

akta.pro primary industry

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)

akta.pro secondary industry

Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA)

Keywords

• 3D cell culture bioreactors
• Rotary cell culture systems
• Bioreactor equipment manufacturing
• Stem cell culture systems
• Perfusion bioreactor systems

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Bioreactor Hardware Sales: Sale of Rotary Cell Culture System (RCCS) bioreactors including single-use disposable vessels and autoclavable vessel systems. Products range from single-vessel systems (RCCS-1) to multi-vessel configurations (RCCS-4, RCCS-8).
2. Stem Cell Culture Systems: Specialized autoclavable vessel systems for stem cell culture in small volumes (1mL, 2mL, 4mL, 10mL sizes), sold as complete systems with rotator base, power supply, and culture vessels.
3. Perfusion Bioreactor Systems: Continuous feeding perfusion bioreactor systems (RCCMax and RCCMax Dual) with oxygenator and peristaltic pump components for advanced 3D culture applications.
4. Custom Bioreactor Design and Manufacturing: Design and manufacture of custom 3D cell culture systems tailored to specific applications including decellularization/recellularization, hollow organ culture, and specialized tissue engineering systems.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Synthecon designs, manufactures, and sells 3D cell culture bioreactor systems built on its proprietary Rotary Cell Culture System (RCCS) technology. Its product lines include disposable and autoclavable RCCS bioreactors, small-volume stem cell culture systems, continuous perfusion bioreactors, and custom-engineered bioreactors for specialized tissue and microgravity applications. Customers are primarily research institutions, pharmaceutical and biotechnology companies, and space research organizations.

Product overview

Synthecon specializes in 3D cell culture bioreactor technology, with the Rotary Cell Culture System (RCCS) as the core platform. The product portfolio includes: (1) RCCS 3D Cell Culture Systems - available in disposable versions (RCCS-D, RCCS-2D, RCCS-4D, RCCS-4DQ, RCCS-8D, RCCS-8DQ) and autoclavable versions (RCCS-1, RCCS-4H, RCCS-4HD, STLVs, HARVs); (2) Stem Cell Culture Systems - small-volume autoclavable systems (RCCS-1SC, RCCS-2SC, RCCS-4SC, RCCS-4SCQ) in 1-10 mL vessel sizes; (3) Perfusion Bioreactors - RCCMax and RCCMax Dual for continuous media perfusion; and (4) Custom Designed Bioreactors including FLOW CELL for specialized applications. The RCCS technology is unique in simultaneously integrating co-culture capability, low shear force, and high mass transfer to encourage spheroid formation. The company has 32 years of experience with over 2,000 published research articles using their systems.

Differentiator

Problem solved

Functional benefit

Brands

• RCCS: Rotary Cell Culture System - the company's flagship 3D cell culture technology for culturing suspension and anchorage-dependent cells
• RCCMAX
• HARV
• STLV

Products and services

• RCCS 3D Cell Culture Systems (Rotary Cell Culture System) The Rotary Cell Culture System (RCCS) is a 3D cell culture bioreactor platform for culturing both suspension and anchorage-dependent cells, integrating low shear force, high mass transfer of nutrients, and co-culture capability to enable spheroid formation. Sold to research institutions, pharmaceutical and biotech companies, and space biology programs.
• Stem Cell Culture Systems Small-volume autoclavable bioreactor systems (1–10 mL vessel sizes) for 3D stem cell culture, including differentiation, maintenance, tissue engineering, and cell therapy applications. Sold as complete systems with rotator base, power supply, and culture vessels to stem cell research laboratories.
• Perfusion Bioreactor Systems RCCMax and RCCMax Dual perfusion bioreactor systems providing continuous feeding of the cell culture chamber from an external media bottle, with 3D aggregates retained by a porous perfusion core; includes oxygenator, peristaltic pump, and power supply components for advanced 3D culture applications.
• Custom Designed Bioreactors Custom-engineered 3D cell culture systems manufactured to customer specifications for specialized applications, including decellularization/recellularization, explant maintenance, blood vessel culture, hollow organ culture, modeled microgravity systems, and FLOW CELL flow cell configurations.

Quantifiable outcome

• Over 700 peer-reviewed publications demonstrating technology validation

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• NASA (National Aeronautics and Space Administration)foundationalTechnology or IntegrationThe Rotary Cell Culture System (RCCS) technology was originally developed by NASA at Johnson Space Center for space research applications. NASA continues to be a key research partner using Synthecon's technology for microgravity studies and space biology research. The technology was designed to simulate microgravity conditions for cell and tissue culture experiments supporting space exploration and understanding cellular behavior in space-like environments.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• PBS Biotech: PBS Biotech manufactures single-use bioreactors for cell culture and bioprocessing, including the Vertical-Wheel technology that competes directly with Synthecon's rotating wall vessel in stem cell and cell therapy applications.
• Cellexus: Cellexus makes the CELL-tainer single-use bioreactor for cell culture and microbial applications, providing another rotating/mixed-vessel approach that competes with Synthecon's RCCS in research and process development workflows.

Broad incumbents

• Corning Life Sciences: Corning provides cell culture vessels, microcarriers, and 3D culture systems used in the same research and bioprocess applications as Synthecon's RCCS bioreactors, often as complementary or alternative solutions for spheroid and 3D culture work.
• Sartorius: Sartorius is a leading global supplier of bioprocessing equipment including the ambr and BIOSTAT bioreactor families, serving the same pharma, biotech, and academic customers as Synthecon but at much greater scale and with a broader product portfolio.
• Thermo Fisher Scientific: Thermo Fisher's Gibco and Finesse bioreactor lines (including the single-use bioreactor portfolio) compete with Synthecon's RCCS in cell therapy and bioprocessing applications, backed by far larger R&D and global service infrastructure.
• Cytiva: Cytiva (formerly GE Healthcare Life Sciences) offers the Xuri cell expansion system and WAVE bioreactors targeting cell therapy and bioprocessing customers that overlap with Synthecon's research and cell therapy user base.
• Eppendorf: Eppendorf supplies New Brunswick bioreactors and a wide range of cell culture and bioprocess lab equipment, overlapping with Synthecon's RCCS systems in academic and pharma research labs worldwide.

Emerging players

• Miltenyi Biotec: Miltenyi Biotec's Prodigy platform automates cell processing and expansion for cell therapy manufacturing, intersecting with Synthecon's stem cell culture system use cases in regenerative medicine and cell therapy development.
• OrganaBio: OrganaBio supplies cell products and 3D culture services using bioreactor-based workflows for cell therapy and regenerative medicine developers, overlapping with Synthecon's stem cell and tissue engineering research customer segments.

Others

• Lonza: Lonza operates the Cocoon cell therapy manufacturing platform and offers cell therapy contract manufacturing services, addressing the same customer pain points as Synthecon's RCCS for 3D cell culture but via a platform-plus-services model rather than discrete bioreactor sales.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/synthecon-incorporated

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synthecon